Loading chat...
IN SB0335
Bill
Status
1/4/2018
Primary Sponsor
Ronald Grooms
Click for details
AI Summary
-
All controlled substance prescriptions must be issued electronically after June 30, 2019, with violators subject to a Class B infraction.
-
Prescribers must complete 3 additional hours of continuing education every 2 years on opioid medication prescribing to continue issuing opioid prescriptions, with a Class B infraction for non-compliance.
-
The Indiana medical licensing board must study and determine by November 1, 2018, whether a waiver from the electronic prescription requirement is necessary due to lack of prescriber capability.
-
If the board determines a waiver is necessary, it must recommend to the general assembly which agency should oversee the waiver process, the reasons for granting waivers, waiver duration, and the length of time a waiver program is needed.
-
The bill becomes effective July 1, 2018, with the board's study requirement expiring December 31, 2018.
Legislative Description
Prescribing of controlled substance. Requires that a controlled substance prescription be issued electronically after June 30, 2019, and establishes a Class B infraction for a prescriber who fails to comply. Requires a prescriber to obtain three hours of continuing education every two years on the prescribing of opioid medication in order to continue issuing prescriptions for opioid medication and establishes a Class B infraction for failure to comply. Requires the medical licensing board of Indiana to study and determine, before November 1, 2018, whether a waiver is necessary for the electronic prescription requirement and to report back to the general
Last Action
First reading: referred to Committee on Health and Provider Services
1/4/2018